| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | EVP, Chief Strategy Officer | Common Stock, $0.01 par value | 53.5K | $8.28M | $154.72 | 16 May 2022 | In trust |
| AbbVie Inc. | EVP, Chief Strategy Officer | Common Stock, $0.01 par value | 41.6K | $6.44M | $154.72 | 16 May 2022 | Direct |
| Neumora Therapeutics, Inc. | President & CEO, Director | Common Stock | 462K | $5.54M | $11.98 | 14 Feb 2024 | Direct |
| Neumora Therapeutics, Inc. | President & CEO, Director | Common Stock | 127K | $1.53M | $11.98 | 14 Feb 2024 | Indirect |
| AbbVie Inc. | EVP, Chief Strategy Officer | Common Stock, $0.01 par value | 3.64K | $563K | $154.72 | 16 May 2022 | Profit sharing trust |
| ACELYRIN, Inc. | Director | Common Stock | 0 | $0 | $2.45 | 21 May 2025 | Direct |
| Neumora Therapeutics, Inc. | President & CEO, Director | Stock Option (Right to Buy) | 160K | 14 Feb 2024 | Direct | ||
| Aptinyx Inc. | Director | Stock Option (Right to Buy) | 40K | 26 May 2022 | Direct | ||
| AbbVie Inc. | EVP, Chief Strategy Officer | Option (Right to Buy) | 0 | $144.54 | 16 May 2022 | Direct | |
| ACELYRIN, Inc. | Director | Director Stock Option (right to buy) | 0 | 21 May 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SLRN | ACELYRIN, Inc. | 21 May 2025 | 3 | $0 | 4 | Director | 23 May 2025, 16:07 |
| SLRN | ACELYRIN, Inc. | 07 Jun 2024 | 1 | $0 | 4 | Director | 11 Jun 2024, 19:11 |
| NMRA | Neumora Therapeutics, Inc. | 14 Feb 2024 | 2 | $0 | 4 | President & CEO, Director | 16 Feb 2024, 16:15 |
| NMRA | Neumora Therapeutics, Inc. | 19 Sep 2023 | 1 | $189K | 4 | President & CEO, Director | 19 Sep 2023, 22:47 |
| NMRA | Neumora Therapeutics, Inc. | 14 Sep 2023 | 0 | $0 | 3 | President & CEO, Director | 14 Sep 2023, 19:58 |
| SLRN | ACELYRIN, Inc. | 09 May 2023 | 3 | $900K | 4 | Director | 11 May 2023, 21:06 |
| SLRN | ACELYRIN, Inc. | 04 May 2023 | 0 | $0 | 3 | Director | 04 May 2023, 19:46 |
| APTX | Aptinyx Inc. | 26 May 2022 | 1 | $0 | 4 | Director | 31 May 2022, 16:31 |
| ABBV | AbbVie Inc. | 16 May 2022 | 3 | -$13M | 4/A | EVP, Chief Strategy Officer | 20 May 2022, 17:03 |
| ABBV | AbbVie Inc. | 01 Mar 2022 | 4 | -$3.68M | 4/A | EVP, Chief Strategy Officer | 20 May 2022, 17:00 |
| ABBV | AbbVie Inc. | 25 Feb 2022 | 4 | -$6.73M | 4 | EVP, Chief Strategy Officer | 01 Mar 2022, 17:14 |
| ABBV | AbbVie Inc. | 17 Feb 2022 | 5 | $0 | 4 | EVP, Chief Strategy Officer | 22 Feb 2022, 16:39 |
| ABBV | AbbVie Inc. | 07 Sep 2021 | 2 | $0 | 4 | EVP, Chief Strategy Officer | 10 Sep 2021, 17:01 |
| APTX | Aptinyx Inc. | 27 May 2021 | 1 | $0 | 4 | Director | 01 Jun 2021, 16:36 |